Abstract: Ruthenium of a metal gate (MG) and/or a middle end of line (MEOL) structure is annealed to reduce, or even eliminate, seams after the ruthenium is deposited. Because the annealing reduces (or removes) seams in deposited ruthenium, electrical performance is increased because resistivity of the MG and/or the MEOL structure is decreased. Additionally, for MGs, the annealing generates a more even deposition profile, which results in a timed etching process producing a uniform gate height. As a result, more of the MGs will be functional after etching, which increases yield during production of the electronic device.

Abstract: An additive composition comprises phosphate ester anions conforming to a specified structure, aromatic carboxylate anions, optionally cycloaliphatic dicarboxylate anions, aluminum (III) cations, sodium cations, optionally calcium cations, optionally lithium cations, and optionally zinc (II) cations. The anions are present in the additive composition in specified molar percentages. The cations are also present in the additive composition in specified molar percentages.

Abstract: A polymer composition comprises a polypropylene polymer and a salt of a branched alkyl phosphonic acid.

Abstract: An composition comprises a first component and one or more calcium cis-1,2-cyclohexanedicarboxylate salts. The first component is selected from thermoplastic polymers, waxes, and mixtures thereof. 25 mol. % or more of the calcium cis-1,2-cyclohexanedicarboxylate salts present in the composition are calcium cis-1,2-cyclohexanedicarboxylate monohydrate. A method for producing a polymer composition entails mixing the composition with a polyolefin polymer, melting the resulting admixture, and letting the admixture solidify to produce a polymer composition.

Abstract: A polymer composition comprises a polypropylene polymer and a salt of a branched alkyl phosphonic acid.

Abstract: An additive composition comprises an antioxidant and one or more calcium cis-1,2-cyclohexanedicarboxylate salts. 25 mol. % or more of the calcium cis-1,2-cyclohexanedicarboxylate salts present in the additive composition are calcium cis-1,2-cyclohexanedicarboxylate monohydrate. A method for producing a thermoplastic polymer composition entails mixing the additive composition with a thermoplastic polymer, melting the resulting admixture, and letting the admixture solidify to produce a polymer composition.

Abstract: A polymer composition comprises a polypropylene polymer and a salt of a branched alkyl phosphonic acid.

Abstract: An additive composition comprises an antioxidant and one or more calcium cis-1,2-cyclohexanedicarboxylate salts. 25 mol. % or more of the calcium cis-1,2-cyclohexanedicarboxylate salts present in the additive composition are calcium cis-1,2-cyclohexanedicarboxylate monohydrate. A method for producing a thermoplastic polymer composition entails mixing the additive composition with a thermoplastic polymer, melting the resulting admixture, and letting the admixture solidify to produce a polymer composition.

Abstract: An additive composition comprises phosphate ester anions conforming to a specified structure, aromatic carboxylate anions, optionally cycloaliphatic dicarboxylate anions, aluminum (III) cations, sodium cations, optionally calcium cations, optionally lithium cations, and optionally zinc (II) cations. The anions are present in the additive composition in specified molar percentages. The cations are also present in the additive composition in specified molar percentages.

Abstract: An additive composition comprises one or more calcium cis-1,2-cyclohexanedicarboxylate salts. 25 mol. % or more of the calcium cis-1,2-cyclohexanedicarboxylate salts present in the additive composition are calcium cis-1,2-cyclohexanedicarboxylate monohydrate. The additive composition has a gravimetric water content of about 20% or less. A method for producing a thermoplastic polymer composition entails mixing the additive composition with a thermoplastic polymer, melting the resulting admixture, and letting the admixture solidify to produce a polymer composition.

Abstract: An additive composition comprises one or more calcium cis-1,2-cyclohexanedicarboxylate salts. The calcium 1,2-cyclohexanedicarboxylate salts have a BET specific surface area of 20 m2/g or more. A method for producing a thermoplastic polymer composition entails mixing the additive composition with a thermoplastic polymer, melting the resulting admixture, and letting the admixture solidify to produce a polymer composition.

Abstract: An additive composition comprises one or more calcium cis-1,2-cyclohexanedicarboxylate salts. 25 mol. % or more of the calcium cis-1,2-cyclohexanedicarboxylate salts present in the additive composition are calcium cis-1,2-cyclohexanedicarboxylate monohydrate. The additive composition has a gravimetric water content of about 20% or less. A method for producing a thermoplastic polymer composition entails mixing the additive composition with a thermoplastic polymer, melting the resulting admixture, and letting the admixture solidify to produce a polymer composition.

Abstract: The present invention is directed to ophthalmic devices that are loaded with therapeutic agent. The devices provide prolonged release of the therapeutic agent to the eye. The ophthalmic devices are typically formed of an ophthalmic material that is particularly desirable for the loading of therapeutic agent and/or the therapeutic agent is typically particularly desirable for loading to the ophthalmic material.

Abstract: An additive composition comprises phosphate ester anions conforming to a specified structure, aromatic carboxylate anions, optionally cycloaliphatic dicarboxylate anions, aluminum (III) cations, sodium cations, optionally calcium cations, optionally lithium cations, and optionally zinc (II) cations. The anions are present in the additive composition in specified molar percentages. The cations are also present in the additive composition in specified molar percentages.

Abstract: The present invention is directed to ophthalmic devices that are loaded with therapeutic agent. The devices provide prolonged release of the therapeutic agent to the eye. The ophthalmic devices are typically formed of an ophthalmic material that is particularly desirable for the loading of therapeutic agent and/or the therapeutic agent is typically particularly desirable for loading to the ophthalmic material.

Abstract: The present invention is directed to ophthalmic devices that are loaded with therapeutic agent. The devices provide prolonged release of the therapeutic agent to the eye. The ophthalmic devices are typically formed of an ophthalmic material that is particularly desirable for the loading of therapeutic agent and/or the therapeutic agent is typically particularly desirable for loading to the ophthalmic material.

Abstract: A polyethylene article comprises crystalline polyethylene in an orthorhombic unit cell. The b-axes of the crystalline polyethylene are substantially aligned with the machine direction of the article. In particular, the Herman's index of the b-axes in the machine direction is greater than zero and greater than the Herman's indices of the b-axes in both the transverse and normal directions. The unique physical attributes exhibited by a polyethylene article having this new morphology are also described.

Abstract: The present invention is directed to ophthalmic devices that are loaded with therapeutic agent. The devices provide prolonged release of the therapeutic agent to the eye. The ophthalmic devices are typically formed of an ophthalmic material that is particularly desirable for the loading of therapeutic agent and/or the therapeutic agent is typically particularly desirable for loading to the ophthalmic material.

Abstract: The present invention is directed to ophthalmic devices that are loaded with therapeutic agent. The devices provide prolonged release of the therapeutic agent to the eye. The ophthalmic devices are typically formed of an ophthalmic material that is particularly desirable for the loading of therapeutic agent and/or the therapeutic agent is typically particularly desirable for loading to the ophthalmic material.

Abstract: The invention provides a thermoplastic polymer composition comprising a polyolefin polymer and a nucleating agent. The nucleating agent comprises a compound conforming to the structure of Formula (I) The invention also provides a series of compounds encompassed by the structure of Formula (I).